Regular Pulse Checks for Patients with Non-cardioembolic Stroke in Rehabilitation Hospitals to Improve Recognition and Detection of Atrial Fibrillation (the ESCORT Study): Protocol for a Prospective Multicenter Observational Study

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Sep 4

PMID 37662047

Authors

Takehiro Katano

Satoshi Suda

Tomohiro Ohta

Mitsusuke Miyagami

Yuzo Kodaira

Chimori Konaka

Masakazu Nagashima

Kazumi Kimura

Affiliations

Soon will be listed here.

Abstract

Background: Cryptogenic stroke (CS) are heterogeneous in origin; however, most CS are embolic mechanism. Paroxysmal atrial fibrillation (AF) is suspected to be a major type of CS that leads to severe cerebral infarction without anticoagulant use. Therefore, the identification of AF is vital in patients with CS. However, patients are often unaware of AF because they have no symptoms, and AF may not be detected on an electrocardiogram (ECG) or Holter ECG on admission. After patients with stroke are treated in the acute phase, they are promptly transferred to a rehabilitation hospital for functional recovery. Once the patient is transferred to a hospital, a few attempts are made to detect AF. In addition, rehabilitation therapists are considered to have insufficient awareness of the possibility of undiagnosed AF.

Objective: This study aimed to increase the understanding of the importance of AF detection in patients with ischemic stroke among therapists in rehabilitation hospitals and to investigate whether regular pulse screening can aid in the detection of AF. If AF was detected, we determined the rate and timing of AF detection and identified the patient characteristics.

Methods: This multicenter prospective observational study aimed to detect AF in patients with non-cardiac stroke at rehabilitation hospitals. Therapists performed pulse checks before, during, and after rehabilitation. If arrhythmia or tachycardia was detected, an ECG was performed, and the physician checked for AF. If the patient complained of chest symptoms, electrocardiography (ECG) was performed to check for AF. We investigated the characteristics, laboratory data, cognitive status, complications, such as stroke recurrence, and functional outcomes of patients with AF.

Results: The study is in the enrollment phase. Recruitment began in September 2022 and will end in August 2023. Patients have provided written informed consent. The main results have been submitted for publication in your journal.

Conclusion: The findings of this study will help identify patients with AF in rehabilitation hospitals and improve awareness among therapists.

References

Bernstein R, Kamel H, Granger C, Piccini J, Sethi P, Katz J . Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. JAMA. 2021; 325(21):2169-2177. PMC: 8170544. DOI: 10.1001/jama.2021.6470. View

Feinberg W, Blackshear J, Laupacis A, Kronmal R, Hart R . Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995; 155(5):469-73. View

Camm A, Fox K, Peterson E . Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention. Europace. 2017; 20(1):1-11. DOI: 10.1093/europace/eux086. View

Hart R, Diener H, Coutts S, Easton J, Granger C, ODonnell M . Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4):429-38. DOI: 10.1016/S1474-4422(13)70310-7. View

Sanna T, Diener H, Passman R, Di Lazzaro V, Bernstein R, Morillo C . Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014; 370(26):2478-86. DOI: 10.1056/NEJMoa1313600. View

Suda S, Katano T, Kitagawa K, Iguchi Y, Fujimoto S, Ono K . Detection of Atrial Fibrillation Using Insertable Cardiac Monitors in Patients With Cryptogenic Stroke in Japan (the LOOK Study): Protocol for a Prospective Multicenter Observational Study. JMIR Res Protoc. 2023; 12:e39307. PMC: 10141259. DOI: 10.2196/39307. View

Senoo K, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R . Distribution of first-detected atrial fibrillation patients without structural heart diseases in symptom classifications. Circ J. 2012; 76(4):1020-3. DOI: 10.1253/circj.cj-12-0105. View

Ziegler P, Glotzer T, Daoud E, Wyse D, Singer D, Ezekowitz M . Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke. 2010; 41(2):256-60. DOI: 10.1161/STROKEAHA.109.571455. View

Wolf P, Abbott R, Kannel W . Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22(8):983-8. DOI: 10.1161/01.str.22.8.983. View

10.

Gladstone D, Spring M, Dorian P, Panzov V, Thorpe K, Hall J . Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014; 370(26):2467-77. DOI: 10.1056/NEJMoa1311376. View

11.

Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I . Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol. 2008; 137(2):102-7. DOI: 10.1016/j.ijcard.2008.06.029. View

12.

Steffel J, Verhamme P, Potpara T, Albaladejo P, Antz M, Desteghe L . The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018; 39(16):1330-1393. DOI: 10.1093/eurheartj/ehy136. View